Congruence Therapeutics
Congruence Therapeutics operates as a biotechnology company.
Based, Congruence Therapeutics works in biotechnology, medical, founded in 2021.
Congruence Therapeutics is positioned in biotechnology, medical, a segment that rewards a clear, focused offering.
The company is listed at the Series_A stage of development.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $64.6M.
| Sector | Biotechnology, Medical |
|---|---|
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $64,581,196 |
Website: congruencetx.com
Browse related
Sign in to view the contact information we hold for Congruence Therapeutics.
Create a free account
Create a free account